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Background: The present article presents the protocol for a randomised controlled trial to test the effectiveness
of a group-based self-management support programme for recently diagnosed type 2 diabetes mellitus (T2DM)
patients (one to three years post-diagnosis) and their partners. The course aims to support T2DM patients and their
partners in successfully integrating diabetes care into their daily lives and hereby enhance self-management and
diabetes-specific health-related quality of life. The content of the course is based on the Common-Sense Model of
Self-Regulation (CSM). Furthermore, principles from the Social Cognitive Theory (SCT) and social support theories
are integrated.
Methods/Design: We aim to recruit 160 recently diagnosed T2DM patients and their partners from general
practices in six different regions in the Netherlands. Patients need to be diagnosed with T2DM for one to three
years and have to experience some degree of diabetes-related difficulties, as measured with a three-item screener.
Participating patients and their partners are randomly allocated to the intervention or control condition. Participants
in the intervention condition receive three monthly group sessions and a booster session three months later.
Participants in the control condition receive a single information meeting. Data will be collected at baseline (T0),
directly after the programme (T1) and six months post-programme (T2), including: self-management, diabetes-specific
health-related quality of life, illness perceptions, attitudes, social support and empowerment. A three-level multilevel
model will be used to compare change-scores between the conditions (intervention/control) on each outcome.
Discussion: Our study will be the first to determine whether a group-based support programme based on the CSM is
effective in enhancing self-management and diabetes-specific health-related quality of life in recently diagnosed T2DM
patients. The important role of patients’ partners in effective diabetes care is also acknowledged in the study.
Trial registration: Netherlands National Trial Register (NTR) NTR3302.
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The prevalence of type 2 diabetes mellitus (T2DM) is in-
creasing to epidemic proportions. Worldwide, more than
300 million people are diagnosed with T2DM and this
number is expected to increase with 50% over the next
20 years [1]. Although T2DM usually starts as a mild
condition, its chronic and progressive nature, the neces-
sity for considerable lifelong lifestyle changes and serious
long-term complications can place a major burden on
individuals and their families [2,3], as well as health care
systems [4].
Effective diabetes-management by patients has been
proven to reduce the chances of serious adverse events
[5] and, consequently, maintain quality of life [6,7] and
keep health care costs manageable [8]. However, this
does require patients to adopt a complex, multifaceted
behavioural regimen, comprising the management of
symptoms, treatment and lifestyle changes, as well as
dealing with the psychological and psychosocial conse-
quences related to the illness. Moreover, these behav-
iours need to be embedded within existing lifestyles,
goals and priorities. Not surprisingly, a fair proportion
of T2DM patients perceives the daily management of
diabetes to be challenging or even burdensome and
experiences difficulties in adequately engaging in self-
care activities [9,10], which might consequently impact
on quality of life [7].
Recognition of the comprehensiveness of diabetes
management has led to the development of many self-
management support programmes [11,12]. However,
few have taken the specific challenges that may arise
during the early phases of living with T2DM into account.
Directly from the onset, T2DM patients are required to
make lifestyle changes and adhere to treatment recom-
mendations, mostly in the absence of diabetes-related
symptoms or complaints. Hence, patients’ motivation to
engage in self-management should therefore primarily
result from their beliefs on the likelihood of adverse
events occurring, as well as beliefs on personal control
and effectiveness of treatment in order to prevent these
serious undesirable events [13]. However, according to
a review by Thoolen et al., [14], recently diagnosed
patients tend to downplay the seriousness of their own
condition. In addition, patients seem to be primarily
concerned with the day-to-day hassles in diabetes man-
agement, rather than the possibility of serious complica-
tions in the long term. These attitudes and perceptions
are likely to contribute to the finding that relatively few
patients appear to be adequately engaged in the recom-
mended (changes in) lifestyle behaviours within the first
year after diagnosis [14].
In the past decades, patients’ perceptions on illness
and treatment were identified to be important precur-
sors for health behaviour change [15]. According to theCommon-Sense Model of Self-Regulation (CSM) [16,17],
illness perceptions act as a framework for the coping
strategies chosen by patients to deal with the illness
and are closely related to behavioural adaption, phys-
ical recovery and psychological well-being in various
chronic illnesses [18]. Moreover, previous studies have
shown that illness perceptions and, consequently,
health related behaviours and outcomes can be suc-
cessfully changed by short interventions based on CSM
principles [19-21].
Accumulating evidence shows that not just the pa-
tients’ illness perceptions, but also the perceptions of
partners are of great importance for understanding
how patients respond to a chronic illness [22]. Illness
perceptions held by partners guide their coping re-
sponses to the patients’ illness, including the way to
give support to patients. Previous studies in T2DM
have shown that social support can enhance as well as
hinder self-management behaviours in patients, par-
ticularly dietary and exercise behaviours [22,23]. A
small number of studies even suggested that partners’
illness perceptions can influence disease outcomes, with
negative or incongruent perceptions being associated with
worse physical, psychological and social functioning
[24,25]. Hence, even though patients themselves are
primarily responsible for managing their illness, it seems
important that partners are structurally involved in dia-
betes care.
Given the importance to intervene at an early stage in
T2DM and the promising results of previous studies
based on the CSM, we developed the ‘Living with dia-
betes’ course: a group-based self-management support
programme specifically tailored to T2DM patients and
their partners in the first years of living with diabetes.
With this new course, we aim to support both patients
and partners in successfully integrating diabetes (care) into
their daily lives and, hereby, enhancing self-management
and diabetes-specific health-related quality of life in T2DM
patients. Psychological and social aspects, including percep-
tions and attitudes, empowerment and social support, are
integrated in the course because of their known important
role in behaviour change [26] (Figure 1). A more detailed
description of the content and underlying theories of the
course can be found elsewhere (van Puffelen et al., 2013
submitted).Aims and hypotheses
The primary aim of this study is to test the effective-
ness of the ‘Living with diabetes’ course on enhancing
self-management behaviours and diabetes-specific health-
related quality of life in T2DM patients (one to three
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Figure 1 Theoretical model of the programme.
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the group-based self-management support programme will
result in:
a) Enhanced self-management and diabetes-specific
health-related quality of life directly after the
programme and at six months post-programme, as
compared to an attention control condition.
Furthermore, we hypothesise that participation in the
group-based self-management support programme will
result in patients:
b) Holding more adaptive illness perceptions and attitudes
towards T2DM;
c) Experiencing more activating partner support;
d) Feeling more empowered to manage their condition
Directly after the programme and at six months post-
programme, as compared to an attention control condition.Methods/Design
Study design
The effectiveness of the programme will be evaluated
by a randomised controlled trial with two follow-up
measurements: immediately after the programme (T1)
and six months after T1 (T2) (Figure 2).Study population
Patients will be recruited via general practitioners (GPs)
who are willing to invite eligible patients to participate in
the study. In the Netherlands, all inhabitants are registered
in a general practice. Therefore, a representative sample
can be drawn.Inclusion criteria
Being diagnosed with T2DM for one to three years, as
recorded by their GP.Exclusion criteria
 Not being able to speak, read and/or understand the
Dutch language sufficiently according to their GP;
 Having insufficient mental or intellectual capabilities
to participate in the study, according to their GP;
 Currently receiving treatment for severe psychological
or psychiatric conditions, according to their GP;
 Recently diagnosed with a severe or life-threatening
comorbid condition (e.g. cancer, CVA);
 Not experiencing any degree of diabetes-related
difficulty or uncertainty, as assessed with a
three-item screening questionnaire.Recruitment
The study population will be recruited from participating
general practices in different regions in the Netherlands
(North, West, Southwest and center). Eligible patients are
selected from the medical records of the participating gen-
eral practices and receive a written invitation for participa-
tion via their GP. Patients fill in an informed consent form
as well as a short screening questionnaire, developed to
identify patients who experience at least some degree
of difficulty or challenge regarding their T2DM self-
management. The questionnaire includes two ques-
tions of the Appraisal of Diabetes Scale (ADS) [27] and
one statement of the Revised Illness Perception Question-
naire (IPQ-R) [28], assessing diabetes-related uncertainty,
coping with diabetes and perceived consequences of
diabetes on life. Patients with a total sum score of zero,
indicating that they do not experience any difficulties or
Table 1 Screening questionnaire
1. How much uncertainty do you currently experience in your life as a result of being diabetic?
None at all Slight amount Moderate amount Large amount Extremely large
(0) (1) (1) (1) amount (1)
2. How effective are you in coping with your diabetes?
Not at all Slightly effective Moderately Very effective Extremely effective
(1) (1) effective (1) (0) (0)
3. My diabetes has major consequences on my life.
Strongly disagree Disagree Neither agree nor Agree Strongly agree
(0) (1) disagree (1) (1) (1)
Inclusion
Eligible patients identified by GP
Patient approached and invited to participate
Informed consent
Randomisation (n = 160 patients)
Intervention (n =80 patients) Control (n = 80 patients)
Group-based support programme
Session 1: illness perceptions 
Session 2: goals and action plans
Session 3: social support
1.5 hour information meeting
Booster session (week 21)
Post-test measurement (T1) (week 9)
Baseline measurement (T0) (week 1)
Sc 1
Post-test measurement (T2) (week 33)
Exclusion
Figure 2 Flow of participants.
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excluded from the study (see Table 1).
Allocation to conditions
After obtaining the signed informed consent form, patients
will be randomly allocated to the intervention or control
condition. Randomisation will be conducted electronically
by a researcher who is not involved in the study.
Intervention
Participants allocated to the intervention group are invited
to take part in the group-based self-management support
programme, together with their partner. Patients who do
not have a partner, are instructed to bring a close friend or
relative instead. Each course group consists of six to ten
patients, accompanied by their partner (or close friend/
relative). The course consists of three two-hour monthly
meetings and one follow-up meeting (‘booster session’)
after three months. The group sessions are led by two
trained diabetes nurses or practice nurses and are delivered
in medical and community centers in the different regions.
Framework The ‘Living with diabetes’ course is based on
the Common-sense Model of Self-Regulation [16,17], the
Social Cognitive Theory [29,30] and principles of social
support theories [31-33]. Content of the course is derived
from previous psychosocial interventions focusing on
illness perceptions [19,20,34]. The emphasis of the course is
on stimulating beneficial illness perceptions and challenging
misconceptions of T2DM in patients and partners. Another
important aspect of the course is the enhancement of
activating partner support for patients, by exploring
patients’ needs for support and discussing supportive inter-
actions with patients and partners. Goal setting and action
plan development are used as techniques to improve
patients’ empowerment and elicit self-management behav-
iour change. All sessions are group-based, providing the
opportunity for peer modeling, social reinforcement, motiv-
ation and emotional support.
Materials Participants receive a handbook with (home-
work) assignments, and practical and theoretical infor-
mation about the topics discussed during the sessions.
In addition, basic information about diabetes and its
treatment is provided in the handbook. For the diabetes
or practice nurses who guide the course sessions, a
detailed manual has been developed.
Pilot The course was pilot-tested on feasibility and
acceptability in November and December 2011. Sixteen
T2DM patients and eight partners from a general practice
in the region of Utrecht participated in the pilot-study
(attrition rate 21.6%). During the pilot, all course sessions
were led by a health psychologist in order to evaluatewhether the correct psychological models and techniques
were used. During the first session, a practice nurse was also
present to provide medical information on T2DM. Feasibil-
ity and acceptability of the course were explored by means
of an evaluation form at the end of the course and by feed-
back of the participants during the course sessions. Based
on the evaluation of the pilot, the manual was adapted
and a screening questionnaire was developed for the RCT
to ensure that only T2DM patients who experience some
degree of difficulties or uncertainties will participate.
Training Prior to the course, the participating nurses
receive a four-hour training, led by a health psychologist
who was also involved in the development of the course
(MH). During this training, the nurses receive informa-
tion on the underlying theories on which the course is
based. Furthermore, the nurses are instructed on how to
use the workbook and manual of the course. Assignments
of the course are explained in detail and tips and tricks on
how to execute these assignments provided. Lastly, first
experiences of the pilot and resulting important topics of
interest are discussed.
Attention control condition
Participants in the attention control condition are invited
to a single 1.5 – hour information meeting, together with
their partner (or close friend/relative). During this meet-
ing, patients and their partners receive medical informa-
tion about diabetes (e.g. causes, complications, treatment)
from a professor in general practice and diabetes care. The
information meeting serves as an attention control condi-
tion to control for the attention paid to being diagnosed
with T2DM when participating in this study. Hence, the
information that patients and partners receive during the
information meeting is provided according to the classical
didactic method; i.e. providing information that is import-
ant from a medical point of view, but not tailored to the
specific and more comprehensive needs of the patients.
Measures
Patients fill in a questionnaire at baseline (T0), immediately
after the programme (T1) and six months post-programme
(T2) to assess the effectiveness of the programme on the
longer term. The primary outcome measures are self-
management and diabetes-specific health-related quality of
life. Secondary outcomes are illness perceptions, attitudes
towards diabetes, partner support and empowerment.
Primary outcome measures
Self-management is measured by using the revised Sum-
mary of Diabetes Self-Care Activities measure (SDSCA)
[35]. The revised SDSCA contains 11 items, measuring six
separate domains: general diet (2 items), specific diet (2
items), exercise behaviours (2 items), glucose monitoring (2
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items are rated on an eight -point Likert scale, measur-
ing the number of days a certain self-care behaviour is
performed during the last week (0–7 days). The 11th
item measures smoking (yes/no) and the number of
cigarettes smoked. Each of the domains is measured
separately. The revised SDSCA shows an adequate in-
ternal consistency and test-retest reliability and is sen-
sitive to change. The measure has been validated
against other measures of diet and exercise [35].
Diabetes-specific health-related quality of life is assessed
by the Problem Areas in Diabetes scale (PAID) [36], measur-
ing diabetes-related emotional distress. The PAID consists
of 20 items on a five -point Likert scale, ranging from 0 (not
a problem) to 4 (a serious problem). Scores are transformed
into a 0–100 scale for interpretation, with higher scores indi-
cating greater diabetes-related emotional distress. The PAID
has a strong concurrent and discriminant validity [37], has
been proven to be responsive to change [38] and has been
validated for Dutch T2DM patients [36,37].
Secondary outcome measures
Cognitive and emotional illness perceptions are assessed
with the IPQ-R [28]. The first section of the IPQ-R mea-
sures different symptoms experienced by patients and
whether they believe these symptoms are caused by their
diabetes (identity scale; 14 items). The second section of
the IPQ-R consists of seven subscales, measuring ‘time-line
acute/chronic’ (6 items); ‘time-line cyclical’ (4 items); ‘con-
sequences’ (6 items); ‘personal control’ (6 items); ‘treatment
control’ (5 items); ‘coherence’ (understanding of T2DM, 5
items) and ‘emotional representation’ (6 items). In the third
section, patients’ causal believes (18 items) are measured.
The ‘identity scale’ is measured dichotomously (yes/no). All
other items are measured on a five-point Likert scale ran-
ging from 1 (strongly disagree) to 5 (strongly agree). The
subscales of the IPQ-R have a good internal consistency
and an acceptable test-retest stability [28].
Attitudes towards diabetes are measured with the
Diabetes Attitude Scale (DAS-3) [39]. The DAS-3 consists
of five subscales, measuring perceived seriousness (7 items);
psychosocial impact (6 items); patient autonomy (8 items);
value of tight control (7 items) and need for special training
(5 items). The items are measured on a five-point Likert
scale ranging from 1 (strongly disagree) to 5 (strongly
agree). The DAS-3 is considered a reliable and valid general
measure of diabetes-related attitudes across different
groups of patients and health care professionals [39].
Patients’ perceptions of partner support are assessed by
using a questionnaire developed by Buunk, Sanderman,
and Nieuwland [40], which measures three different di-
mensions of partner support; active engagement (5 items);
protective buffering (8 items) and overprotection (6 items).
The items are measured on a five-point Likert scaleranging from 1 (never) to 5 (always). The three subscales
have a moderate to good internal consistency [40].
Patient empowerment is assessed by the Dutch Diabetes
Empowerment Scale (Dutch DES-20) [41]. The question-
naire consists of five subscales, assessing dissatisfaction
and goal achievement (6 items), coping and motivation
(4 items), obtaining support (3 items), overcoming barriers
(4 items) and determining suitable methods (3 items) in a
five-point Likert scale, ranging from 1 (totally disagree) to
5 (totally agree). The Dutch DES-20 was found to be a
reliable and valid instrument [41].
Sample size
The sample size calculation is based on detecting a clin-
ically relevant change on the PAID, as a result of the
programme. Since there is no consensus on the minimal
important difference (MID) on the PAID, we decided to
set the MID at half a standard deviation (SD); a com-
monly used solution when scores have no direct inter-
pretation and no clinical results exist to determine a
relevant percentage [42]. In Dutch T2DM patients, the
SD found on the PAID was 20, with a mean score of
22.5 points (scale 0–100) [36]. To establish a 10-point
difference with the power set at 80% and the α at .05
(two-sided), 63 patients are needed in each condition
(intervention/control). However, taking the clustering of
patients within groups into account, an oversampling of
15% is needed to conduct multi-level analyses. When
accounting for an additional drop-out of 10%, 2 × 80
patients will have to be recruited.
Statistical analysis
The study is a two-arm randomised controlled trial with
repeated measures over time and continuous outcome
variables. Descriptive statistics (mean values and fre-
quencies) will be calculated to evaluate the scores on
primary and secondary outcome measures on T0, T1
and T2 separately. The effectiveness of the programme
will be analysed by a three-level multilevel model: groups,
patients and measurements (T0, T1, and T2). This type
of analysis allows us to both test the main effectiveness
of the condition, its effectiveness over time, as well
as the interaction effects of condition (intervention/
control) × time. By including groups as a separate level
in the analysis, possible effects of the different regions,
course leaders and group climate are corrected for. Data
will be analysed according to the intention-to-treat
principle. All analyses will be performed using MLwiN.
Ethical approval
The protocol, information letters and informed con-
sent form of the study were approved by the Medical
Ethical Committee of the VU University Medical
Center Amsterdam.
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This article describes the design of the ‘Living with diabetes’
study: a study testing the effectiveness of a group-based
self-management support programme for people known to
be diagnosed with T2DM for one to three years and their
partners. The content of the course is based on principles
of the CSM, SCT and social supportive theories and is spe-
cifically designed to build more adaptive (activating) illness
perceptions and attitudes, increase empowerment, stimu-
late activating social support and, consequently, enhance
self-management and diabetes specific health-related qual-
ity of life in recently diagnosed T2DM patients.
Previous research already emphasised the importance
of the integration of patients’ and partners’ illness per-
ceptions in self-management interventions, because of
their ability to change and their close link to health be-
haviours and outcomes [15,19-21]. With this study, we
will contribute to the literature by providing insight into
the effectiveness of a group-based method to build and
alter illness perceptions in patients with chronic illness,
rather than an individual programme. Furthermore, to our
knowledge, we are the first to conduct such programme in
T2DM patients and partners in the first years of living
with T2DM.
A particular strength of the study is that the programme
‘Living with diabetes’ is well grounded in theory. Major psy-
chological models on behaviour change, such as Leventhal’s
Common Sense Model [16,17] and Bandura’s Social Cogni-
tive Theory [29,30] provide the framework for the course.
By incorporating social support theories and actively involv-
ing the patients’ partners, we account for the influence of
social support on self-management behaviours in patients.
Group discussions provide patients with the opportunity to
share experiences and learn from others through peer mod-
elling and peer support [43]. Consequently, the course goes
beyond the mere provision of information and skills train-
ing and starts explicitly from both patients’ and partners’
experiences, needs and concerns. In addition, this study
specifically focusses on patient important outcomes rather
than solely medical outcomes (e.g. HbA1c), comprising
emotional, cognitive and behavioural outcomes.
The current study also poses a number of challenges
and drawbacks. We foresee a few potential threats to re-
liability and generalisability of the study. First, a selec-
tion of participating patients in the study is expected, as
a result of a selective non-response of patients of older
age and patients from the non-western origin. Conse-
quently, specific target groups might be missed and gener-
alisability of the results of this study limited. Furthermore,
a possible selection bias might also be found among the
GPs in the study. Participating GPs will probably represent
a group more open to research and innovation and may
also be more motivated to improve diabetes care. Con-
sequently, their patients might already receive variouseducational or support programmes which may negatively
impact on participation willingness. In order to keep non-
response and drop-out rates as low as possible, persona-
lised invitation letters from GPs and reminders to initial
non-responders will be sent. Furthermore, the course
sessions and information meetings will be organised in
easily accessible locations in the area of the participat-
ing patients and GPs. Finally, a practical challenge is
also foreseen in the group-based format of the course.
In spite of the fact that group-based sessions pose many
advantages, they are more difficult to organise and can-
not be completely adapted to individuals needs and
preferences (e.g. time, location, topics discussed), which
may result in increased (selective) drop-out. Further-
more, we emphasise the importance of creating and
keeping a positive and stimulating group climate during
the course sessions. Dominant and/or negative group
members can negatively influence the group climate
and interactions, and consequently, the effectiveness of
the programme. Therefore, we will recruit diabetes
nurses and practice nurses who already have experience
in leading group-based courses and extra attention will
be paid on how to deal with dominant group members
during the training.
The results of this RCT will provide valuable informa-
tion on the effectiveness and feasibility of group-based
self-management support programmes, focusing on illness
perceptions and social support. The course is well suited
for implementation in a primary health care setting. The
course is fully manualised and supported by a training to
ensure the possibility of replication. Furthermore, the
group-based setting of the course is less time and money
consuming than individual support programmes. Hence,
if proven effective, the course can be utilised by general
practices and diabetes care groups as an addition to the
individual patient education provided by health care
professionals and already available patient education
programmes in T2DM. First results of the study are
expected in the spring of 2014.
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